Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astellas Pharma Inc (ALPMF)
OTHER OTC:ALPMF
Astellas Pharma (ALPMF) Stock Price & Analysis
35 Followers
ALPMF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.96 - $17.00
Previous Close$9.7
Volume12.00K
Average Volume (3M)3.58K
Market Cap
$17.61B
Enterprise Value$14.96B
Total Cash (Recent Filing)¥413.30B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)147.6
Beta0.37
Next Earnings
Jul 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.93%
Share Statistics
EPS (TTM)0.06
Shares OutstandingN/A
10 Day Avg. Volume5,734
30 Day Avg. Volume3,585
Standard Deviation0.07
R-Squared0.01
Alpha-0.00272
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
ALPMF FAQ
What was Astellas Pharma Inc’s price range in the past 12 months?
Astellas Pharma Inc lowest stock price was $8.96 and its highest was $17.00 in the past 12 months.
What is Astellas Pharma Inc’s market cap?
Currently, no data Available
When is Astellas Pharma Inc’s upcoming earnings report date?
Astellas Pharma Inc’s upcoming earnings report date is Jul 30, 2024 which is in 87 days.
How were Astellas Pharma Inc’s earnings last quarter?
Astellas Pharma Inc released its earnings results on Apr 25, 2024. The company reported -$0.125 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.125.
Is Astellas Pharma Inc overvalued?
According to Wall Street analysts Astellas Pharma Inc’s price is currently Overvalued.
Does Astellas Pharma Inc pay dividends?
Astellas Pharma Inc does not currently pay dividends.
What is Astellas Pharma Inc’s EPS estimate?
Astellas Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Astellas Pharma Inc have?
Astellas Pharma Inc has 1,809,663,100 shares outstanding.
What happened to Astellas Pharma Inc’s price movement after its last earnings report?
Astellas Pharma Inc reported an EPS of -$0.125 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.237%.
Which hedge fund is a major shareholder of Astellas Pharma Inc?
Currently, no hedge funds are holding shares in ALPMF
---
Astellas Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.53%
12-Months-Change
Fundamentals
Return on Equity
0.96%
Trailing 12-Months
Asset Growth
27.78%
Trailing 12-Months
Company Description
Astellas Pharma Inc
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
---
ALPMF Company Deck
---
ALPMF Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---